about
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI B...
Read More
1.74
-0.04
(-2.25%)
26,739
XNAS Volume
XNAS 10 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
GRI Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..